Lung Cancer Clinical Trials in Chicago, IL

Lung Cancer Clinical Trials in Chicago, IL

View the best 10 lung cancer medical studies in Chicago, Illinois. Access promising new therapies by applying to a Chicago-based Lung Cancer clinical trial.

Top rated lung cancer clinical trials in Chicago, Illinois

Here are the top 10 medical studies for lung cancer in Chicago, Illinois

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Docetaxel +3 More

Anti-metabolites

Recruiting1 awardPhase 2
This trial is studying giving maintenance chemotherapy with or without local consolidation therapy to see if it works better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.
Image of Alaska Oncology and Hematology, LLC. in Anchorage, United States.

Sacituzumab Govitecan-hziy (SG) +1 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial will compare overall survival of two treatments for lung cancer patients who have progressed after other treatments.
Image of UC San Diego Moores Cancer Center in La Jolla, United States.

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 1
This trial is testing a combination of two immunotherapy drugs to see if they're more effective than either drug alone in treating HIV-associated classical Hodgkin lymphoma or solid tumors.
Image of Stanford Cancer Institute in Palo Alto, United States.

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new combination treatment for lung cancer patients who have not responded to other treatments.
Image of VA Long Beach Healthcare System, Long Beach, CA in Long Beach, United States.

Stereotactic Radiotherapy +1 More

Radiation Therapy

Recruiting1 award16 criteria
This trial is testing whether surgery or stereotactic radiotherapy is better for people with stage I non-small cell lung cancer.
Image of Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro in Jonesboro, United States.

Stereotactic Body Radiation Therapy

Radiation

Recruiting2 awardsPhase 3
This trial is testing whether adding atezolizumab to radiation therapy works better than just radiation therapy alone in treating patients with early non-small cell lung cancer.
Image of GenHarp Clinical Solutions in Evergreen Park, United States.

IMP4297

PARP Inhibitor

Recruiting1 awardPhase 1 & 2
This trial looks at a new cancer treatment for advanced solid tumors and ES-SCLC, focusing on safety, tolerability and effectiveness.
Image of Saint Bernards Medical Center in Jonesboro, United States.

Romiplostim

Recruiting1 awardPhase 3
This trial looks at whether a drug called romiplostim can help cancer patients receiving chemotherapy to get their full dose on time.
Image of Alabama Oncology - Grandview in Birmingham, United States.

Sitravatinib +2 More

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial will compare the effectiveness of sitravatinib when given with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression after platinum-based chemotherapy and checkpoint inhibitor therapy.
Image of GSK Investigational Site in Lone Tree, United States.

Pembrolizumab

Recruiting1 awardPhase 3
This trial is testing if adding niraparib to pembrolizumab maintenance therapy could improve progression-free survival and overall survival in participants with advanced or metastatic non-small cell lung cancer who have achieved stable disease, partial response, or complete response following completion of standard of care first-line platinum-based induction chemotherapy with pembrolizumab.

Popular filter options for lung-cancer chicago trials

Phase 3 Clinical Trials

View 100 phase 3 medical studies.

Clinical Trials With No Placebo

View 100 medical studies that do not have a placebo group.

View More Lung-cancer Chicago Trials

See another 85 medical studies focused on lung-cancer chicago.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.